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Abstract: In artisanal small-scale gold mining, mercury is used for gold-extraction, putting miners
and nearby residents at risk of chronic metallic mercury vapor intoxication (CMMVI). Burden of
disease (BoD) analyses allow the estimation of the public health relevance of CMMVI, but until now
there have been no specific CMMVI disability weights (DWs). The objective is to derive DWs for
moderate and severe CMMVI. Disease-specific and generic health state descriptions of 18 diseases
were used in a pairwise comparison survey. Mercury and BoD experts were invited to participate in
an online survey. Data were analyzed using probit regression. Local regression was used to make the
DWs comparable to the Global Burden of Disease (GBD) study. Alternative survey (visual analogue
scale) and data analyses approaches (linear interpolation) were evaluated in scenario analyses. A total
of 105 participants completed the questionnaire. DWs for moderate and severe CMMVI were 0.368
(0.261–0.484) and 0.588 (0.193–0.907), respectively. Scenario analyses resulted in higher mean values.
The results are limited by the sample size, group of interviewees, questionnaire extent, and lack
of generally accepted health state descriptions. DWs were derived to improve the data basis of
mercury-related BoD estimates, providing useful information for policy-making. Integration of the
results into the GBD DWs enhances comparability.
Keywords: mercury; artisanal small-scale gold mining; chronic metallic mercury vapor intoxication;
burden of disease; disability weights; pairwise comparison; visual analogue scale
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1. Introduction
Artisanal small-scale gold mining (ASGM) is a poverty-driven activity practiced by an estimated
16 million gold miners worldwide [1]. Large quantities of mercury are used to extract gold from
ore resulting in a high mercury exposure of miners and residents in ASGM areas [2]. Due to the
informal and often illegal character [3], the public health burden of the mercury exposed gold miners
has not been well studied. Steckling et al. [4] provided a preliminary estimate of the burden of
disease (BoD) attributable to mercury exposure of gold miners in Zimbabwe resulting in an estimate
of 95,400 Disability-Adjusted Life Years (DALYs). Pure Earth and Green Cross Switzerland [5]
made an initial estimate of the global BoD due to ASGM, assuming 1.5 million attributable DALYs.
One of the major limiting factors of these analyses was the lack of a disability weight (DW) for
mercury intoxication, in addition to a generally scarce data basis. BoD analyses are useful to describe
population health by integrating information about mortality and morbidity into a single metric, the
Disability-Adjusted Life Year (DALY). Environmental burden of disease (EBD) is an application of
BoD where the quantified burden is attributed to environmental risk factors. BoD and EBD generate
information relevant for policy-making and prioritization. Indeed, DALYs allow comparing the impact
of diseases and environmental factors across populations and across time [6]. The DALY is a summary
measure of population health (SMPH) comprising the Years of Life Lost (YLL) and the Years Lived
with Disability (YLD). YLLs are quantified by multiplying the number of deaths with a standard
remaining life expectancy at age of death. YLDs are obtained by multiplying the number of incident
cases with the average duration of disability and multiplied with the corresponding disability weight
(DW) [7–9]. Alternatively, the number of prevalent cases can also be used as a measure of disease
frequency, yielding a prevalence perspective for assessing BoD [10,11]. In any case, a DW is a crucial
prerequisite for quantifying YLDs. The DW is a factor between zero and one reflecting the severity
of the health state, defined as the relative reduction in quality of life. A value of zero designates an
optimal health state (i.e., 0% reduction in quality of life), while a value of one indicates a health state
equivalent to death (i.e., 100% reduction in quality of life). Consequently, a severe disease has a higher
DW than a mild disease. Different approaches may be used to derive DWs [12]. DWs of more than
200 health states were recently derived within the Global Burden of Disease (GBD) study [13–15].
However, the list of health states without determined DW is still extensive. The absence of health
state-specific DWs hinders a comparable estimation of the corresponding BoD. Consequently, the
consideration in resource allocation is inhibited. This is the case for chronic intoxication due to the
use of mercury in ASGM. The DiWIntox (Disability Weight for Chronic Mercury Intoxication) project
was initiated to provide additional data in this research field. In the first stage of the project, disease
profiles of moderate and severe chronic metallic mercury vapor intoxication (CMMVI) with generic
and disease-specific descriptions useful for a DW derivation were determined by interviewing experts
with extensive experiences in the field of mercury research and by conducting a systematic literature
search [16]. A mild CMMVI was also confirmed by the experts. However, a differentiation in the two
stages moderate and severe had advantages, while available information describes either CMMVI in
general (what was labeled as the moderate case) or the most severe case of CMMVI [16]. The second
stage of the project, described in this paper, aims to derive DWs for moderate and severe CMMVI
following mercury exposures in ASGM.
2. Materials and Methods
There is no standardized procedure for deriving DWs. However, numerous methodological
approaches are available [12,17]. In general, DWs are based on valuation methods to raise the
respondents preferences or the “relative desirability of a health state compared to” another ([12],
p. 12, based on [18]). Important methodological decisions concern the presentation of health states
which severity should be evaluated (e.g., just a disease label or further disease-specific or generic
descriptions), the panel of respondents (e.g., experts, the general population or people affected), and
the valuation method (common procedures are time trade-off, person trade-off, visual analogue scale,
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and pairwise comparisons) [12,19]. For the DiWIntox project, recent recommendations [12] and the
methodological procedure of the currently largest set of DWs [13,15,20] were considered, accepted,
adapted, or rejected regarding the needs of the recent research aim. Consequently, a combination of
disease-specific and generic descriptions of moderate and severe CMMVI was used and compared
with other health states described in a comparable style (Section 2.1) in an online (Section 2.2) pairwise
comparison experiment (Section 2.3). Additionally, a visual analogue scale was used as second
valuation method to observe result variation (Section 2.4). The panel of respondents comprised experts
(Section 2.5). Data was analyzed with a probit regression in the main analysis (Section 2.6). Details and
reasons to all methodological decisions are given in the following.
2.1. Health State Descriptions
For DW derivation, a combination of disease-specific and generic health state descriptions is
recommended [12]. Corresponding disease descriptions for moderate and severe CMMVI were
developed using an expert interview and a literature review [16]. For the generic part of the description,
the EuroQol (EQ) questionnaire EQ-5D+C-3L was applied to assess the health-related quality of life.
The questionnaire contains the 5 dimensions (5D) mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression, as well as an additional dimension, cognition (+C). Each dimension is assessed
according to one of three levels (3L) of severity, i.e., the lowest level being “no problems”, the next
level “problems”, and the highest level “severe problems”. The EQ-5D+C-3L was chosen because it
was used in previous DW studies to describe health states in a generic style [21–27].
Besides the descriptions of the health states of interest (moderate and severe CMMVI), a set
of further health states was needed to compare their disease severity with the severity of CMMVI.
The inclusion of further health states was necessary, because the valuation method pairwise comparison
was chosen (see Section 2.3), in which the respondents compare two hypothetical individuals with
particular health states and decide who is healthier. The requirements regarding the set of other health
states were that disease-specific and generic (EQ-5D+C-3L) descriptions are available and that the set
contains health states representing the whole spectrum of severities (diseases from low to high severity).
Possible descriptions available from previous studies [21–27] were compared regarding style and length.
These assessments entered into the decision whether to include a study in the DiWIntox project.
Finally, 18 health state descriptions from three sources were included. Twelve descriptions,
representing a wide range from mild to severe health states, were taken from the European DW
project [24]. Three descriptions of disorders attributable to alcoholism were taken from the Dutch
DW project [26]. Alcohol use disorders were included to examine the assumption of previous
research, expecting that the DW for chronic mercury intoxication might be comparable to the DW of
alcoholism [4]. The Dutch study additionally provided the health state description of deafness [26],
which was used as an anchor in a visual analogue scale (VAS, see Section 2.4) within a scenario analysis.
The decision to include the DW of deafness as an anchor was based on the fact that the DW (0.215)
derived by GBD 2013 [15] is in a similar dimension like the DW (0.23) derived or applied in previous
studies [26,28,29]. This consistency of the DW derived in different contexts was the reason of its
application as an anchor in DiWIntox. Finally, the two descriptions of moderate and severe CMMVI
were taken from Steckling et al. [16] and adapted to enhance comparability with the other descriptions.
The final health states descriptions (of moderate and severe CMMVI and the other 16 health states) are
available in Table S1 of the Supplementary Materials.
In the GBD 2013 study, lay descriptions of the symptoms and functional consequences of the
health states developed by expert groups were formulated to enable their accessibility by the general
population [13,15,20]. Using the GBD lay descriptions in DiWIntox—which would lead to direct
comparability—was no option. One reason was that the target group of DiWIntox contained experts
rather than the general population (see Section 2.5). Another reason was that the moderate and severe
CMMVI, as previously defined in Steckling et al. [16] are not generally known and accepted disease
descriptions. Thus, providing disease-specific and generic descriptions, as recommended [12], was
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decided to be the best option. However, to check agreements and differences, health state descriptions
used in DiWIntox and GBD 2013 were compared by one of the authors, documented in Table S1
(Supplementary Materials), and checked by all co-authors. First, the list of GBD health states was
examined to identify GBD health states generally comparable to the DiWIntox health states. The next
step was to identify and extract comparable and not comparable parts of the descriptions. Based on this,
comparability was categorized as “low”, “medium”, or “high” (Table S1, Supplementary Materials).
The comparison was necessary because it was decided to use these DWs of GBD health states to
anchor the DiWIntox DWs in the main analysis, which are moderately or highly comparable with the
DiWIntox health states (see Section 2.6). Due to this anchoring, the development of DWs within the
GBD dimensions was enhanced.
2.2. Data Collection
The online survey tool Unipark (http://www.unipark.com/) was used for data collection.
A pretest was conducted from 2 March to 7 March 2016 to test the comprehension and quality of the
web survey. Feedback from the 24 pretest respondents and lessons learned during the pretest were
taken into account and the final version of the online questionnaire was opened for participation from
27 March to 4 April 2016. The invitation was sent by email to the experts identified (see Section 2.5)
with a request to invite further colleagues from their own research field to participate in the survey by
forwarding the email.
A hyperlink opened the welcome letter and the anonymous survey started when the respondents
gave their informed consent to participate. Content of the survey were pairwise comparison (PC)
questions and a visual analogue scale (VAS) exercise for which answers were obligatory to continue
the survey. Further questions regarding the respondents’ expertise and socioeconomic characteristics
were optional. The survey ended with a free text entry field for comments and a thank you letter
(Table S2, Supplementary Materials).
The questionnaire was available in English. Concerns regarding data protection were discussed
with a data protection officer. An ethical approval was obtained from the ethical committee of Bielefeld
University (ethic project code: 2016-033).
2.3. Pairwise Comparison (PC)
The respondents were asked to compare a person suffering from a defined health state with
a person suffering from another defined health state, and to decide who is healthier overall. Indifference
was not available as an option. Comparing all of the 18 health states with all other health states would
result in 18 × 17 = 306 possible combinations; a number too high for a single respondent to answer.
A feasible questionnaire was created including 10 PC questions per respondent. The health states were
presented using the health state descriptions selected (see Section 2.1).
Participants were randomly assigned to answer one out of seven different sets of 10 PC questions
each. The seven sets differed in the pairs of health states they contained. The pairs as well as the
position of the health states (first or second option) within a PC question were randomly assigned.
The sequence of PC questions within a set was assigned randomly to each participant.
Every health state was presented to every respondent who finalized the questionnaire completely
at least once and at most twice. For each participant, one PC question was repeated in reverse order
to check the test-retest reliability as has been done in previous projects [13,15,29]. The repeated
question included moderate or severe CMMVI in comparison to any other health state. Table S3 in the
Supplementary Materials contains the list of PC questions per set. Figures S2–S17 in the Supplementary
Materials contain screenshots of one complete online questionnaire version.
2.4. Visual Analogue Scale (VAS)
A Visual Analogue Scale (VAS) was included as an add-on in the survey to test result variation in
accordance to an alternative survey method (see Section 2.6, Scenario Analysis 2). The VAS contained
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values from 0, presenting the worst imaginable health state, to 100, presenting the best imaginable
health state. The respondents were asked to indicate the position of one given health state on the scale
by selecting a value between 0 and 100 under consideration of a predefined value of 78 for deafness
(taking into account the DW for deafness derived by Stouthard et al. [26] and Salomon et al. [15]).
The respondents were randomly assigned to evaluate one out of three health states (quadriplegia,
moderate or severe CMMVI). Following the intention to determine the value of an upper anchor also
represented in other studies, quadriplegia was subject to evaluation in five of seven cases. Additionally,
moderate and severe CMMVI were evaluated in one of seven cases each, because these health states
were of main interest in this study.
2.5. Panel Composition
Two subgroups of experts were recruited for participation. Experts involved in the health research
of mercury were asked to participate. These experts were identified by conducting a PubMed search of
health-related mercury articles published in the last five years. The search terms were combinations of
two or all of the three of the following aspects: cause (mercury), effect (represented by the terms disease,
health, intoxication, poisoning), setting (gold mining).
While the answers of the mercury experts might be influenced by their research interest, further
scientists without special research interest in mercury but with general health-related knowledge were
asked to participate. While this broad subgroup definition describes a countless number of possible
participants, a specific focus on BoD experts was chosen. These were identified by a PubMed search
of the term disability weight/s (limitation: last 5 years). The advantages of this strategy are that the
participants are interested in DWs and that they know their importance for BoD research. By inviting
this subgroup, a higher response rate was assumed than by inviting individuals without or with
restricted knowledge about BoD.
The corresponding authors of the mercury and DW paper identified were invited by email to
answer the questionnaire. The invitation (Table S4, Supplementary Materials) included the request to
forward the email to further colleagues from their research field. This was done to increase the number
of participants. At the end of the survey, participants were requested to reveal their expertise to check
whether the group of respondents agreed with the group of invitees.
The study group included experts rather than the general population or affected people.
DWs were derived under the assumption of universality/no consideration of country/culture/
other circumstances.
2.6. Data Management and Analyses
Data obtained by VAS and questions about expertise and socioeconomic information were in
a format which did not require specific adaption before analyses. Descriptive statistics were performed
in SPSS (IBM Corporation, Armonk, NY, USA). Data obtained by the PC questions needed adaption
before analyses. The answers to the PC questions collected by the online questionnaire tool were stored
in 70 PC variables. Three values were possible: 1, the respondent answered that the person with the
first health state is healthier; 2, the respondent answered that the person with the second health state is
healthier; −99, the respondent did not answer the question by closing the survey before finalization or
the question was not presented to the respondent (missing value). Data were stored in a matrix with
one row per participant and one column per PC question.
To analyze the data with probit regression, the matrix had to be changed in one column containing
the results of all PC questions and several rows per participant (e.g., row 1: answer of participant 1
to PC 1; row 2: answer of participant 1 to PC 2, and so on). Outgoing from this, further necessary
variables were generated (Table 1).
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Table 1. List of variables.
Variable Name Number of TheseKind of Variable Variable Values and Value Labels Description and Examples
Q*_hs#vs#
70, one variable for
each pairwise
comparison
1 person with the first health
state is healthier
2 person with the second health
state healthier
−99 missing value
Input variable (exported from internet survey tool).
Variable contains a 1 if the person with the first health state was evaluated as healthier, 2 if the person with
the second health state was evaluated as healthier. Missing values: respondent was not asked to answer the
PC question or respondent closed the survey without answering the pairwise comparison (PC) question.
Examples:
q01_hs03vs01; possible variable values: 1, 2, −99
q01_hs04vs10; possible variable values: 1, 2, −99
q70_hs09vs03; possible variable values: 1, 2, −99
hs1_q*
70, one variable for
each pairwise
comparison
1 breast cancer was health state
one in the pair
2 chronic low back pain was
health state one in the pair
. . . . . .
18 quadriplegia was health state
one in the pair
0 missing value
Variable contains the number of the first health state of the pairwise comparison (PC) question (see Table S1
in the Supplementary Materials for the numbers of health states and the numbers of PC questions). There is
no information in this variable, which health state was chosen as healthier. Missing values: respondent was
not asked to answer the PC question or respondent closed the survey without answering the PC question.
Examples:
hs1_q01; possible variable values: 3, 0
hs1_q02; possible variable values: 4, 0
hs1_q70; possible variable values: 9, 0
hs2_q*
70, one variable for
each pairwise
comparison
1 breast cancer was health state
two in the pair
2 chronic low back pain was
health state two in the pair
. . . . . .
18 quadriplegia was health state
two in the pair
0 missing value
Variable contains the number of the second health state of the PC question (see Table S1 in the
Supplementary Materials for the numbers of health states and the numbers of PC questions). There is no
information in this variable, which health state was chosen as healthier. Missing value: respondent was not
asked to answer the PC question or respondent closed the survey without answering the PC question.
Examples:
hs2_q01; possible variable values: 1, 0
hs2_q02; possible variable values: 10, 0
hs2_q70; possible variable values: 3, 0
healthier_q*
70, one variable for
each pairwise
comparison
1 breast cancer was chosen as
healthier in the pair
2 chronic low back pain was
chosen as healthier in the pair
. . . . . .
18 quadriplegia was chosen as
healthier in the pair
. missing value
Variable contains the number of the health state chosen as healthier in the PC question (see Table S1 in the
Supplementary Materials for the numbers of health states and the numbers of PC questions). Missing value:
respondent was not asked to answer the PC question or respondent closed the survey without answering
the PC question.
Examples:
healthier_q01; possible variable values: 1, 3, 0
healthier_q02; possible variable values: 4, 10, 0
healthier_q70; possible variable values: 9, 3, 0
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Table 1. Cont.
Variable Name Number of TheseKind of Variable Variable Values and Value Labels Description and Examples
dep_var one variable
1 the first health state was chosen
as healthier
0 otherwise
Dependent variable for probit regression. Contains 1 if the first health state was chosen as healthier in the
PC question (see Table S1 in the Supplementary Materials for the number of PC questions); contains 0 if the
first health state was not chosen as healthier, if the respondent was not asked to answer the PC question, or
respondent closed the survey without answering the PC question.
No examples (just one variable with two possible values):
dep_var; possible variable values: 1, 0
indep_var_hs# 18 variables
1 health state was the first option
in the pair
−1 health state was the second
option in the pair
0 missing value
Independent variable for probit regression. For each of the health states, contains 1 if the health state was
the first option in the pair, −1 if the health state was the second option in the pair, and 0 if respondent was
not asked to answer the PC question or if the respondent closed the survey without answering the PC
question. There is no information in this variable, which health state was chosen as healthier
Examples:
indep_var_hs01; possible variable values: 1, −1, 0
indep_var_hs02; possible variable values: 1, −1, 0
indep_var_hs18; possible variable values: 1, −1, 0
gbd_2013 One variable
0.0001 lower bound
0.031 mild vision disorder
. . . . . .
NA moderate CMMVI
. . . . . .
0.589 quadriplegia
NA severe CMMVI
0.9999 upper bound
Dependent variable for the local regression (LOESS). Variable contains GBD 2013 DWs of the 11 health
states, which descriptions are moderately or highly comparable to the descriptions used in DiWIntox
(see Table 2). For the residual 7 health states without moderately or highly comparable descriptions, not
available (NA) was included as placeholder. The values 0.0001 and 0.9999 were added to limit the
0 to 1 scale.
coef One variable
−9999 upper bound
2.803 mild Vision Disorder
. . . . . .
1.024 moderate CMMVI
. . . . . .
0.000 quadripleagia
−0.448 severe CMMVI
−9999 lower bound
Independent variable for LOESS regression. Variable contains the probit regression coefficients of the
18 DiWIntox health states. The scale of the independent variable is infinity; this was expressed by including
the values 9999 and −9999.
The symbols * and # stand for the question and health state number, respectively.
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The results of the PC questions were analyzed using probit regression [13,15,20]. The binary
dependent variable contained 1 when the first health state was chosen as healthier in the PC question
and 0 otherwise. Independent variables were generated for every health state containing 1 when the
health state was the first option in the pair, −1 when the health state was the second option in the
pair, and 0 when the respondent was not asked to answer the PC question or when the respondent
closed the survey without answering the PC question. For quality assurance, the probit regression was
independently run by two researchers using the statistic program R (R Core Team; Vienna, Austria)
and STATA (StataCorp LLC; College Station, TX, USA) respectively.
The probit regression coefficients were translated into DWs by the application of four approaches
(one main analysis and three scenario analyses, Table 2). The main analysis is based on the most
sophisticated approach. Scenario analyses were done to observe result variation by applying alternative
survey and data analyses approaches.
Table 2. Approaches to derive disability weights in main analysis and scenario analyses.
Analysis Survey Instrument Data Analysis Anchor
MA PC probit regression, LOESS function eleven GBD DWs
SA 1 PC
probit regression, rule of three formulas
(Formula (S1) in Table S5 in the Supplementary
Materials, assuming linearity)
two GBD DWs (deafness
and quadriplegia)
SA 2 VAS See Formula (1) one GBD DW (deafness)
SA 3 PC, VAS
probit regression, rule of three formulas
(Formula (S1) in Table S5 in the Supplementary
Materials, assuming linearity)
one GBD DW (deafness) and
one DiWIntox VAS DW
(quadriplegia; taken from SA 2)
Abbreviations: DW, disability weight; GBD, Global Burden of Disease study [15]; LOESS, local regression; MA,
main analysis; PC, pairwise comparison; SA, scenario analysis, VAS, visual analogue scale.
2.6.1. Main Analysis
In the main analysis, local regression (LOESS) was used to translate regression coefficients into
DWs. The dependent variable contained the GBD 2013 DWs of the health states, with descriptions
that are moderately or highly comparable to the descriptions used in DiWIntox (see Section 2.1), while
the independent variable contained the probit regression coefficients of the 18 DiWIntox health states.
The scale of the dependent variable was logit transformed to ensure fitted values would fall, after
back-transformation, within the 0 to 1 range. A bandwidth of 1 was used, which means that 100% of
data were used in smoothing each point. In addition to the observed data points, two theoretical data
points were added to anchor the LOESS fit. The values 0.0001 and 0.9999 were added to the dependent
variable to limit the 0 to 1 scale. The scale of the independent variable is infinity; this was expressed by
including the values 9999 and −9999 (Table 1).
Based on the fitted LOESS model, predictions, with corresponding standard errors, were made for
the probit coefficients, including those for which no GBD 2013 DW was available. An inverse logistic
function was used to back-transform these fitted values to the 0 to 1 scale. To propagate the uncertainty
resulting from the LOESS fitting process, 1,000,000 Monte Carlo simulations were generated from
a normal distribution with mean and standard deviation corresponding to the LOESS estimate and
standard error, respectively. After applying the aforementioned back-transformation, the resulting
uncertainty distribution was summarized by its mean and a 95% uncertainty interval (UI) defined as
the distribution’s 2.5th and 97.5th percentile.
The DiWIntox DWs of the main analysis were compared with the corresponding GBD DWs.
The Spearman’s rank correlation coefficient (Spearman’s Rho) was applied to the mean DiWIntox and
GBD DWs to describe the correlation of these variables.
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2.6.2. Scenario Analysis 1
Two anchor DWs (deafness: 0.215; quadriplegia: 0.589, both taken from GBD 2013) and their
probit coefficients were defined as 100% and 0%. For every regression coefficient of the non-anchor
health states, the resulting percentage was determined using linear interpolation. Tables S5 and S6 in
the Supplementary Materials includes further explanations to convey the fundamental idea behind the
data analyses of PC questions.
2.6.3. Scenario Analysis 2
The results of the VAS regarding moderate and severe CMMVI, as well as quadriplegia were used
in Scenario Analysis 2. VAS data were translated into DWs by applying the following formula:
DW = 1− (VAS value/100) (1)
The values were tested regarding meaningfulness. Criteria for exclusion of not meaningful values
were developed and applied (see Table S7, Supplementary Materials). Minimum, maximum, mean,
and median VAS values with and without exclusion of values were analyzed.
2.6.4. Scenario Analysis 3
Scenario Analysis 3 used the same approach as applied in Scenario Analysis 1, except that the
DW of quadriplegia was taken from the VAS in Scenario Analysis 2 and included as an upper DW
anchor. Thus, Scenario Analysis 3 is most widely independent of GBD with the exception that the DW
of deafness, which was used as a lower anchor, was predefined based on GBD [15,20] and previous
studies [26,28–30].
3. Results
3.1. Descriptive Statistics
On the basis of the PubMed searches, 211 corresponding authors were invited to take part in the
survey. People were invited from all over the world, especially from Europe (29%), Asia (25%), and
North America (25%). Fewer people were invited from South America (9%), Australia/Oceania (7%),
and Africa (5%), what is in accordance to the lower number of publications with the selected keywords
from these continents.
A number of 138 participants agreed to take part in the survey and 105 of them completed the
entire questionnaire. Among these 105 participants, 60% were male, all were adult, most between
30 and 39 years of age (30%), and 75% were from Europe. For 80% of the participants English was not
the native language (Table 3).
Expertise in public health (60% of participants), epidemiology (50%), and BoD (30%) were most
frequently mentioned. Six percent described themselves as mercury experts, while 10% affirmed that
they had ever seen anyone suffering from mercury intoxication. Eighty percent of the participants
were scientists, 11% were medical doctors, 3% were policy-makers, or had other areas of expertise
(Table 3; multiple answers were possible).
One hundred and seven participants answered one question twice in reverse order of health
states. The test-retest reliability reached a value of 86%, representing the interviewees who gave the
same answer to both questions.
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Table 3. Sociodemographic characteristics of the interviewees.
Characteristic Number Percent (n = 105 = 100%,Rounded)
Sex
Male 42 40
Female 63 60
Age
Younger than 21 0 0
21–29 years 21 20
30–39 years 33 31
40–49 years 21 20
50–59 years 19 18
60–69 years 10 10
70 years and older 1 1
Permanent residence
Africa 1 1
Asia 5 5
Australia/Oceania 3 3
Europe 79 75
North America 16 15
South America 0 0
No answer 1 1
Native language English 23 22
Not English 82 78
Expertise *
Burden of Disease 29 27.6
Chemistry 8 7.6
Epidemiology 54 51.4
Medicine 10 9.5
Mercury 6 5.7
Politics 3 2.9
Public Health 59 56.2
Toxicology 6 5.7
Others 19 18.1
No expertise 3 2.9
No answer 1 1.0
Occupation *
Medical doctor 11 10.5
Policy maker 3 2.9
Scientist 82 58.6
Others 16 15.2
No occupation 1 1.0
No answer 0 0.0
Seen someone suffering from
mercury intoxication
Yes 10 9.5
No 94 89.5
No information 1 1.0
Participants Who Opened the Link to the Survey: 140
Participants Who Agreed to Take Part: 138
Participants Who Answered the Survey Completely: 105
* Multiple answers possible.
3.2. Comparability of Health State Descriptions Used in DiWIntox and GBD
The descriptions of the 18 health states included in DiWIntox were used to identify comparable
health states used in GBD 2013. For three of the health states in DiWIntox, there are no comparable
health states in GBD 2013 (moderate CMMVI; severe CMMVI; diabetes). Comparability of three further
health states was evaluated as low (the selected disease stages of breast cancer, colorectal cancer, and
HIV/AIDS).
Moderately comparable are the descriptions for chronic low back pain, deafness, delirium and
mild vision disorder. The remaining eight health state descriptions show high comparability (Table 4).
The GBD DWs of the 11 health states with moderately and highly comparable descriptions to the
DiWIntox descriptions were included in the LOESS fit of the main analysis.
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Table 4. Disability Weights (DWs) of main and scenario analyses in comparison with GBD (Global Burden of Disease) 2013 DWs and comparability of health
state descriptions.
DiWIntox
Ranking
DiWIntox
GBD
Ranking
GBD 2013 DiWIntox vs. GBD 2013
Health States (HS) Used in
DiWIntox (Ordered
by Severity)
DWs
(MA)
95% UI
(MA)
DWs
(SA 1)
DWs
(SA 2)
DWs
(SA 3)
Health State Best
Comparable to
DiWIntox Health State
DWs 95% UI
Comparability
of HS
Description ~
Comparison of
DiWIntox (MA)
and GBD
Results *
1 Mild Vision Disorder 0.081 0.033–0.162 0.119 / 0.060 1 Distance vision,mild impairment 0.031 0.019–0.049 moderate Overlapping UIs
2 Deafness 0.136 0.075–0.221 0.215 # 0.215 # 0.215 # 6 Hearing loss, complete 0.215 0.144–0.307 moderate Overlapping UIs
3
Breast Cancer (Clinically
disease-free stage without
permanent sequelae)
0.162 0.098–0.246 0.248 / 0.268 2 Mastectomy 0.036 0.020–0.057 low Not overlappingUIs
4 Problems of AlcoholDrinking 0.189 0.122–0.274 0.277 / 0.316 7
Alcohol use
disorder: mild 0.235 0.160–0.327 high
Overlapping UIs;
DWs within each
other UI
5 Severe Asthma 0.189 0.122–0.273 0.277 / 0.316 4 Asthma, uncontrolled 0.133 0.086–0.192 high
Overlapping UIs;
DW within each
other UI
6 Chronic Low Back Pain 0.203 0.134–0.288 0.290 / 0.337 10 Low back pain: severe,with leg pain 0.325 0.219–0.446 moderate Overlapping UIs
7 HIV/AIDS (seropositive,asymptomatic) 0.208 0.139–0.293 0.296 / 0.346 3
HIV/AIDS: receiving
antiretroviral treatment 0.078 0.052–0.111 low
Not overlapping
UIs
8 Mild Dementia 0.223 0.152–0.309 0.309 / 0.367 12 Dementia: mild 0.377 0.252–0.508 high Overlapping UIs
9
Diabetes Mellitus
(uncomplicated,
poorly controlled)
0.254 0.178–0.343 0.336 / 0.411 / n.a. n.a. n.a. /
10 Manifest Alcoholism 0.312 0.223–0.413 0.380 / 0.482 11 Alcohol use disorder:moderate 0.373 0.248–0.508 high
Overlapping UIs;
DW within each
other UI
11 Coronary Heart Disease,Severe Stable Angina 0.347 0.248–0.458 0.404 / 0.521 5 Angina pectoris: severe 0.167 0.110–0.240 high
Not overlapping
UIs
12
Chronic Metallic Mercury
Vapor Intoxication
(moderate case)
0.368 0.261–0.485 0.417 0.40 0.542 / n.a. n.a. n.a. /
13
Colorectal Cancer
(Stage of diagnosis and
primary therapy)
0.368 0.261–0.485 0.418 / 0.543 8 Cancer: diagnosis andprimary therapy 0.288 0.193–0.399 low
Overlapping UIs;
DW within each
other UI
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Table 4. Cont.
DiWIntox
Ranking
DiWIntox
GBD
Ranking
GBD 2013 DiWIntox vs. GBD 2013
Health States (HS) Used in
DiWIntox (Ordered
by Severity)
DWs
(MA)
95% UI
(MA)
DWs
(SA 1)
DWs
(SA 2)
DWs
(SA 3)
Health State Best
Comparable to
DiWIntox Health State
DWs 95% UI
Comparability
of HS
Description ~
Comparison of
DiWIntox (MA)
and GBD
Results *
14 Stroke, moderateimpairments 0.431 0.300–0.569 0.458 / 0.608 9
Stroke: long-term
consequences, moderate
plus cognition problems
0.316 0.206–0.437 high
Overlapping UIs;
DW within each
other UI
15 Severe Depression 0.526 0.334–0.713 0.536 / 0.734 15 Major depressivedisorder: severe episode 0.658 0.477–0.807 high
Overlapping UIs;
DW within each
other UI
16 Delirium caused byexcessive alcohol intake 0.537 0.329–0.736 0.549 / 0.755 13
Alcohol use
disorder: severe 0.570 0.396–0.732 low
Overlapping UIs;
DW within each
other UI
17 Quadriplegia 0.560 0.291–0.804 0.589 # 0.82 # 0.82 # 14
Spinal cord lesion at
neck: treated 0.589 0.415–0.748 high
Overlapping UIs;
DW within each
other UI
18
Chronic Metallic Mercury
Vapor Intoxication
(severe case)
0.588 0.194–0.907 0.664 0.80 0.941 / n.a. n.a. n.a. / /
Abbreviations: DiWIntox: Disability Weight for Chronic Mercury Intoxication; GBD: Global Burden of Disease study; HS: health state; MA: main analysis; n.a.: not available;
UI: uncertainty interval. *: Spearman’s Rho applied to the mean DiWIntox DWs of the main analysis and the mean GBD 2013 DWs: 0.77 (p-value < 0.001). #: Predefined value.
~: Comparability of health state descriptions used in DiWIntox and GBD 2013 was checked and documented in Table S1 (Supplementary Materials).
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3.3. Disability Weights
Results of the PC questions were analyzed in the main analysis (Section 3.3.1) as well as in
Scenario Analysis 1 (Section 3.3.2). In Scenario Analysis 2 (Section 3.3.3), the VAS results were analyzed.
Scenario Analysis 3 (Section 3.3.4) used both, results from PC and VAS (Table 2). Consequently, the
following findings were used as starting point in the main analysis and in Scenario Analysis 1 and 3:
In total, 1005 PC questions were answered. According to the probit regression, a person with mild
vision disorder is healthier than a person with any of the other 17 health states. Of all 18 health states
included, severe CMMVI was evaluated as the worst health state following the results of the probit
regression. Table S6 in the Supplementary Materials shows the complete order of health states and
corresponding probit regression coefficients. These coefficients were transformed into DWs using
different approaches in the main analysis (Section 3.3.1) and Scenario Analysis 1 and 3 (Sections 3.3.2
and 3.3.4). Scenario Analysis 2 (Section 3.3.3) used the VAS results and not the coefficients to derive
DWs and additionally provided input to Scenario Analysis 3 (Section 3.3.4).
3.3.1. Main Analysis
The main analysis resulted in a DW of 0.368 (95% UI: 0.261–0.484) for the moderate case of CMMVI
and a DW of 0.588 (95% UI: 0.193–0.907) for the severe case. Figure S1 in the Supplementary Materials
shows the fitted LOESS curve. The dots represent the 11 health states for which moderately and highly
comparable GBD health states are available (Table 4). Table 4 also contains the DWs and UI for all
18 health states considered.
A comparison of the DiWIntox and GBD DWs resulted in the following findings: For the 15 health
states for which DiWIntox and GBD DWs were available, the DiWIntox and GBD UIs of 12 health
states were overlapping. An interesting finding is the following trend: If the GBD and DiWIntox health
state descriptions were highly comparable (n = 8), then the DiWIntox and GBD DWs were within each
other UI (exception: Coronary heart disease). If the comparability of the health state descriptions was
assessed as moderate (n = 3), then the DiWIntox and GBD UIs were overlapping, but the DWs were
not within each other UI. If a low comparability of health state descriptions was identified (n = 4), then
the trend was not clear, while in 2 cases the UIs were not overlapping and in the 2 other cases, the
DiWIntox and GBD DWs were even within each other UI (see last column in Table 4). The correlation
can be described as sufficient by a Spearman’s Rho of 0.77 (p-value < 0.001).
3.3.2. Scenario Analysis 1
In this analysis, linear interpolation of the probit coefficients based on the pairwise comparisons
was done, using the same GBD anchor as in the main analysis. Scenario Analysis 2 resulted in a DW
range of 0.119 for mild vision disorder to 0.664 for severe CMMVI. The DW for moderate CMMVI was
0.417 (Table 4).
3.3.3. Scenario Analysis 2
Besides the results of the PC questions used in the Main Analysis and Scenario Analysis 1 and
3, Scenario Analysis 2 used the VAS results what resulted in DWs for not more than 3 health states
(instead of 18). The integration of moderate and severe CMMVI as well as quadriplegia on a VAS
resulted in a mixed picture. The respondents attributed a wide range of values to each of the three
health states, resulting in DWs ranging from 0.10 to 1.00 for quadriplegia, 0.15 to 0.93 for severe
CMMVI, and 0.00 to 0.80 for moderate CMMVI. The wide range of values determined supports the
assumption that some participants had misunderstood the question. Consequently, it was necessary
to identify and exclude not meaningful values. These outliers were defined as values which are
obviously wrong; namely values higher than the predefined value for deafness (VAS value: 0.78).
Based on this rule, 6 values were excluded for quadriplegia, 3 for moderate CMMVI, and one value
for severe CMMVI. The median after exclusion of obviously wrong values resulted in a DW of 0.82
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for quadriplegia, 0.80 for severe CMMVI, and 0.40 for moderate CMMVI (Table S7, Supplementary
Materials). The order of quadriplegia and severe CMMVI is converse in comparison to the results of
the main analysis.
3.3.4. Scenario Analysis 3
Scenario Analysis 3 used the same approach like number 1 with the difference that the VAS DW
of quadriplegia derived in Scenario Analysis 2 (see Section 3.3.3) was used as upper anchor instead of
the GBD DW. The analysis resulted in a DW range of 0.060 for mild vision disorder to 0.941 for severe
CMMVI. The DW for moderate CMMVI was 0.542. The DWs of all 18 health states are presented in
Table 4.
4. Discussion
DiWIntox is the first project that has derived DWs for mercury intoxication resulting in 0.368
(UI: 0.261–0.484) for moderate and 0.588 (UI: 0.193–0.907) for severe CMMVI in the main analysis.
DWs of further 16 health states were presented (Table 4). Previous studies aiming on estimating
the DALYs caused by the use of mercury in ASGM were limited due to the missing DW [4,5].
Others focused on renal toxicity due to inorganic mercury [31] or mild mental retardation due to
methylmercury [32] including but not limited to ASGM. The results of the current study improve the
data basis of BoD analyses while a more precise estimation of the number of DALYs attributable to the
use of mercury in ASGM is possible. Thus, the comparability with other diseases and risk factors is
enhanced and may give important insights about the relevance of this neglected public health issue.
Besides the main analysis, scenario analyses applying alternative survey and data analyses
approaches were presented. The DWs derived in the main analysis were made comparable to the GBD
2013 DWs [15]. A significant and sufficient Spearman’s Rho was determined, indicating a positive
correlation between the DiWIntox and GBD DWs. Thus, the general dimension of the DiWIntox DWs
is comparable with those of the largest BoD study available, although methodological differences and
restrictions were not avoidable. Meant are especially the use of different health state descriptions and
the distinctly smaller number of survey participants in DiWIntox in comparison to GBD.
The DWs derived in scenario analyses with alternative survey and data analyses approaches
provided information about methodological aspects and corresponding result variation as well as
results (more) independent of GBD 2013.
The order of health states according to their severity in terms of DWs, as derived in the current
analyses, is predominately comprehensible. However, there is one inconsistent result depending on
the survey instrument (VAS vs. PCs). The VAS resulted in DWs for quadriplegia and severe CMMVI are
close with a slightly higher DW for quadriplegia. PCs resulted in a distinct higher DW for severe CMMVI
in comparison to quadriplegia. A higher severity of severe CMMVI in comparison to quadriplegia
was initially not assumed; however, when comparing the presented EQ-5D+C-3L categorizations, with
333221 for quadriplegia [24] and 233333 for severe CMMVI [16], the result is reasonable.
It would have been beneficial to have a health state included in this survey with a higher severity
than severe CMMVI. This was—according to the high severities in the GBD 2013 study [33]—assumed
for severe depression and quadriplegia. The fact that severe CMMVI was the health state on the upper
end of the derived DWs might have contributed to the large UI.
When comparing the order of moderately or highly comparable health state descriptions derived
in DiWIntox and GBD 2013 according to the DW value, the following discrepancies arise: the DiWIntox
analyses result in a comparable severity of problems of alcohol drinking and severe asthma; GBD 2013
presents a higher DW for the first mentioned. The order of mild dementia and manifest alcoholism is
different; however the GBD 2013 DWs of these health states are ranked similarly. The health states
coronary heart disease and stroke (moderate impairments) were evaluated as less severe in GBD
2013 than in DiWIntox. Severe depression reached a higher DW than quadriplegia in GBD 2013,
although close to each other in ranking. In contrast, the interviewees in the DiWIntox project judged
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quadriplegia to be more severe than severe depression. As mentioned before, comparability is limited
by different health state descriptions. Additionally, in the GBD 2013 study, a large sample size of
more than 60,000 interviewees of the general world population were included [33], while in DiWIntox,
a small sample of little more than 100 experts took part. Furthermore, some methodological adaptions
of the GBD 2013 design were necessary, e.g., population health equivalence questions were not applied
in DiWIntox.
In a preliminary estimation of the DALYs attributable to chronic mercury intoxication in
Zimbabwe [4], a provisional DW of 0.18 was assumed because a specific DW was not available.
The DW was taken from the GBD 1990 study describing the severity of alcohol dependence [8].
The DW of this health state was chosen, because the cause of alcohol dependence is also a substance,
the health state is chronic, and similar neuropsychological symptoms are observed as in chronic
mercury intoxication [4]. Due to methodological changes during data collection, different health state
descriptions, and another group of interviewees, the DWs of the old and recent GBD study are not
comparable. However, the congruent health state of alcohol dependence in the DiWIntox project is
manifest alcoholism (Table S1, Supplementary Materials). The DW of manifest alcoholism (DW: 0.312)
is very close to but below the DW of moderate CMMVI (DW: 0.368). Thus, the previous assumption,
that the severity of chronic mercury intoxication is comparable to the severity of alcohol dependence is
confirmed as reasonable.
In the DiWIntox project, respondents were recruited by identifying relevant publications and
inviting the corresponding authors with the request to forward the invitation to colleagues. The final
group of respondents agrees partially with the group of invitees. The corresponding authors of papers
about mercury and DW research were invited, however, not more than 6% and less than 30% of
respondents identified themselves as a mercury or DW expert, respectively. Due to the recruitment
strategy applied, especially public health experts (n = 59) and epidemiologists (n = 54) were reached.
Only a few participants (n = 6) confirmed that they had expertise regarding mercury and 10% stated
that they saw someone who was mercury intoxicated. Mercury experts could be influenced by their
research interest in mercury which could result in a specific response behavior. It is possible that
scientists involved in mercury research perceive a higher disease severity of health effects due to
mercury than those not involved. To control such effects, the survey was opened for further experts
without involvement in mercury research. While finally just a few participants described themselves as
a mercury expert, this possible source of bias is not assumable. Consequently, a stratified analysis with
the focus on mercury experts seemed not useful because of the restricted number of participants in
this subgroup. This point should again be taken up in future research, because mercury experts might
have a better understanding of mercury attributable health effects which could imply an enhanced
ability to evaluate the severity of such effects.
The 211 people directly invited to take part in the survey, as identified by PubMed searches, came
mostly from Europe (29%), closely followed by North America (25%), and Asia (25%). This order is
repeated in the final sample of participants; however, European interviewees are overrepresented
with 75% (North America: 15%; Asia: 5%). A reason might be that the invitation to the survey was
sent out from Europe. It can be assumed, that the research institution that sent the questionnaire,
is better known by the European colleagues, which might have convinced them to participate or to
forward the invitation to colleagues. Due to the request to invite colleagues, the total number of
people who received the invitation is not known. Besides the small number of invitations sent out to
South America (n = 20), Australia/Oceania (n = 14), and Africa (n = 11), a reason for non-participation
could be a language barrier for South America and some parts of Africa, because the questionnaire was
exclusively available in English. This is also relevant for the final group of participants, because 80%
of them had a native language other than English. Consequently, responses to the survey questions
could be influenced by misunderstandings.
Within the project, it was possible to include 18 health states with available corresponding
descriptions which were mostly comparable. These were used for pairwise comparisons. Seven sets
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of pairs were provided and randomly assigned to the participants. Based on the project extent and
the assumed low number of participants, this magnitude of variation seemed suitable. Three of the
18 health states were used for VAS, while most participants integrated quadriplegia onto the scale
(n = 74) and just a few integrated moderate (n = 24) and severe (n = 16) CMMVI. More attention
was given to quadriplegia, because this health state was thought to define the upper end of the
severity dimension. The VAS value of quadriplegia was applied in Scenario Analysis 3. Asking for
the integration of CMMVI was an add-on to collect more information about mercury intoxication.
All in all, VAS resulted in a mixed picture with a wide range of answers. The resulting mean and
median DWs are higher than the DWs of the main analysis using PC. Higher values obtained by VAS
in comparison to other valuation methods have been reported in earlier studies [12,23,34,35].
In summary, the project results are limited by the low number of diseases and the restricted
variation of possible pairs presented for evaluation. DiWIntox is a small project with a low number of
respondents. Some sub-analyses, like the integration of CMMVI into the VAS, are especially restricted
by the number of respondents. The recruitment of participants was limited by predefined criteria.
This strategy did not result in participation of a sufficient number of mercury experts. Among the
respondents, European experts for public health, epidemiology and BoD were highly represented,
for most of whom the survey was in a foreign language. As result of the PCs, severe CMMVI was
identified as the most severe health state considered in this study, which might be the reason for the
large UI.
The current results improve the data basis of BoD analyses what enhances the comparability of
this condition with other diseases and risk factors. With the DWs derived for moderate and severe
CMMVI, a more precise estimation of the number of DALYs attributable to the use of mercury in
ASGM is possible. Understanding the public health relevance by determining DALYs gives important
insights about the relevance and need for burden reduction of this neglected issue.
Future research should focus on the following aspects to further improve BoD analyses:
The disease-specific health states descriptions and EQ-5D+C-3L categorizations as well as the
derivation of DWs should be verified by the conduction of surveys including a representative number
of health professionals having experience with mercury intoxicated patients or with personally
interviewing patients themselves. Further relevant health states such as mild cases of CMMVI,
childhood CMMVI, as well as intoxication due to methylated mercury, need to be described (including
disease-specific and generic aspects) and evaluated. The prevalence of CMMVI in ASGM and its
distribution in disease stages must be surveyed.
5. Conclusions
The present study is the first to derive DWs of moderate and severe CMMVI to improve the data
basis of mercury-related BoD estimates. This is important to estimate the disease burden attributable
to the use of mercury in ASGM. The DWs were smoothed into the GBD 2013 DWs to enhance
comparability. In accordance with the results of the DiWIntox project, around 37% (UI: 26% to 48%)
of a life year should be counted within an estimation of the BoD in terms of DALYs, if the life year is
lived with a moderate CMMVI. For severe cases of CMMVI, a very high severity was ascertained (DW:
0.588, UI: 0.193–0.907), even above the severity of quadriplegia and severe depression. Future research
should further strengthen the data basis regarding mercury-related health effects in gold mining to
improve estimates about its public health relevance.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/14/1/57/s1,
Figure S1: Graph of the local regression (LOESS) function; Figure S2: Screenshot of page one of one online
survey version; Figure S3: Screenshot of page two of one online survey version; Figure S4: Screenshots of page
three of one online survey version; Figure S5: Screenshot of page four of one online survey version; Figure S6:
Screenshot of page five of one online survey version; Figure S7: Screenshot of page six of one online survey version;
Figure S8: Screenshot of page seven of one online survey version; Figure S9: Screenshot of page eight of one
online survey version; Figure S10: Screenshot of page nine of one online survey version,; Figure S11: Screenshot
of page ten of one online survey version; Figure S12: Screenshot of page eleven of one online survey version;
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Figure S13: Screenshot of page twelve of one online survey version; Figure S14: Screenshot of page thirteen of
one online survey version; Figure S15: Screenshot of page fourteen of one online survey version; Figure S16:
Screenshot of page fifteen of one online survey version; Figure S17: Screenshot of page sixteen of one online
survey version; Table S1: Comparison of health state descriptions; Table S2: Structure of the online questionnaire;
Table S3: Pairwise comparisons of the seven questionnaire versions; Table S4: Email invitation and reminders
to answer the online questionnaire; Table S5: Explanation of Scenario Analysis 1 using a simple linear model to
derive disability weights outgoing from two anchors; Table S6: Regression coefficients, percentages outgoing
from two anchor and resulting disability weights using a simple linear model (according to scenario Analysis 1);
Table S7: Results of integrating quadriplegia, moderate chronic metallic mercury vapor intoxication (CMMVI),
and severe CMMVI into a visual analogue scale (VAS; 0: worst imaginable health state; 100: best imaginable
health state) with deafness (value 78) predefined and applying exclusion criteria for outlier control.
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